img

Global Migraine Drugs Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Migraine Drugs Market Research Report 2024

According to Mr Accuracy reports’s new survey, global Migraine Drugs market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Migraine Drugs market research.
Key manufacturers engaged in the Migraine Drugs industry include Allergan, Merck, Pfizer, Teva, Pfizer, Johnson & Johnson, Endo International, GlaxoSmithKline and Impax, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Migraine Drugs were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Migraine Drugs market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Migraine Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Allergan
Merck
Pfizer
Teva
Pfizer
Johnson & Johnson
Endo International
GlaxoSmithKline
Impax
Abbott
Bayer
Eli Lilly
Ethypharm
Kowa Pharmaceuticals America
Winston Pharmaceuticals
AstraZeneca
Segment by Type
Sumatriptan
Zolmitriptan
Rizatriptan
Others Drug

Segment by Application


Hospitals
Clinics
Household Use
Others

Consumption by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Migraine Drugs report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Migraine Drugs Market Overview
1.1 Product Overview and Scope of Migraine Drugs
1.2 Migraine Drugs Segment by Type
1.2.1 Global Migraine Drugs Market Value Comparison by Type (2024-2034)
1.2.2 Sumatriptan
1.2.3 Zolmitriptan
1.2.4 Rizatriptan
1.2.5 Others Drug
1.3 Migraine Drugs Segment by Application
1.3.1 Global Migraine Drugs Market Value by Application: (2024-2034)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Household Use
1.3.5 Others
1.4 Global Migraine Drugs Market Size Estimates and Forecasts
1.4.1 Global Migraine Drugs Revenue 2018-2034
1.4.2 Global Migraine Drugs Sales 2018-2034
1.4.3 Global Migraine Drugs Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Migraine Drugs Market Competition by Manufacturers
2.1 Global Migraine Drugs Sales Market Share by Manufacturers (2018-2024)
2.2 Global Migraine Drugs Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Migraine Drugs Average Price by Manufacturers (2018-2024)
2.4 Global Migraine Drugs Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Migraine Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Migraine Drugs, Product Type & Application
2.7 Migraine Drugs Market Competitive Situation and Trends
2.7.1 Migraine Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Migraine Drugs Players Market Share by Revenue
2.7.3 Global Migraine Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Migraine Drugs Retrospective Market Scenario by Region
3.1 Global Migraine Drugs Market Size by Region: 2018 Versus 2022 Versus 2034
3.2 Global Migraine Drugs Global Migraine Drugs Sales by Region: 2018-2034
3.2.1 Global Migraine Drugs Sales by Region: 2018-2024
3.2.2 Global Migraine Drugs Sales by Region: 2024-2034
3.3 Global Migraine Drugs Global Migraine Drugs Revenue by Region: 2018-2034
3.3.1 Global Migraine Drugs Revenue by Region: 2018-2024
3.3.2 Global Migraine Drugs Revenue by Region: 2024-2034
3.4 North America Migraine Drugs Market Facts & Figures by Country
3.4.1 North America Migraine Drugs Market Size by Country: 2018 VS 2022 VS 2034
3.4.2 North America Migraine Drugs Sales by Country (2018-2034)
3.4.3 North America Migraine Drugs Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Migraine Drugs Market Facts & Figures by Country
3.5.1 Europe Migraine Drugs Market Size by Country: 2018 VS 2022 VS 2034
3.5.2 Europe Migraine Drugs Sales by Country (2018-2034)
3.5.3 Europe Migraine Drugs Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Migraine Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Migraine Drugs Market Size by Country: 2018 VS 2022 VS 2034
3.6.2 Asia Pacific Migraine Drugs Sales by Country (2018-2034)
3.6.3 Asia Pacific Migraine Drugs Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Migraine Drugs Market Facts & Figures by Country
3.7.1 Latin America Migraine Drugs Market Size by Country: 2018 VS 2022 VS 2034
3.7.2 Latin America Migraine Drugs Sales by Country (2018-2034)
3.7.3 Latin America Migraine Drugs Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Migraine Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Migraine Drugs Market Size by Country: 2018 VS 2022 VS 2034
3.8.2 Middle East and Africa Migraine Drugs Sales by Country (2018-2034)
3.8.3 Middle East and Africa Migraine Drugs Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Migraine Drugs Sales by Type (2018-2034)
4.1.1 Global Migraine Drugs Sales by Type (2018-2024)
4.1.2 Global Migraine Drugs Sales by Type (2024-2034)
4.1.3 Global Migraine Drugs Sales Market Share by Type (2018-2034)
4.2 Global Migraine Drugs Revenue by Type (2018-2034)
4.2.1 Global Migraine Drugs Revenue by Type (2018-2024)
4.2.2 Global Migraine Drugs Revenue by Type (2024-2034)
4.2.3 Global Migraine Drugs Revenue Market Share by Type (2018-2034)
4.3 Global Migraine Drugs Price by Type (2018-2034)
5 Segment by Application
5.1 Global Migraine Drugs Sales by Application (2018-2034)
5.1.1 Global Migraine Drugs Sales by Application (2018-2024)
5.1.2 Global Migraine Drugs Sales by Application (2024-2034)
5.1.3 Global Migraine Drugs Sales Market Share by Application (2018-2034)
5.2 Global Migraine Drugs Revenue by Application (2018-2034)
5.2.1 Global Migraine Drugs Revenue by Application (2018-2024)
5.2.2 Global Migraine Drugs Revenue by Application (2024-2034)
5.2.3 Global Migraine Drugs Revenue Market Share by Application (2018-2034)
5.3 Global Migraine Drugs Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Allergan
6.1.1 Allergan Corporation Information
6.1.2 Allergan Description and Business Overview
6.1.3 Allergan Migraine Drugs Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Allergan Migraine Drugs Product Portfolio
6.1.5 Allergan Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Migraine Drugs Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Merck Migraine Drugs Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Migraine Drugs Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Pfizer Migraine Drugs Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Teva
6.4.1 Teva Corporation Information
6.4.2 Teva Description and Business Overview
6.4.3 Teva Migraine Drugs Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Teva Migraine Drugs Product Portfolio
6.4.5 Teva Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Migraine Drugs Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Pfizer Migraine Drugs Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Corporation Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Migraine Drugs Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Johnson & Johnson Migraine Drugs Product Portfolio
6.6.5 Johnson & Johnson Recent Developments/Updates
6.7 Endo International
6.6.1 Endo International Corporation Information
6.6.2 Endo International Description and Business Overview
6.6.3 Endo International Migraine Drugs Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Endo International Migraine Drugs Product Portfolio
6.7.5 Endo International Recent Developments/Updates
6.8 GlaxoSmithKline
6.8.1 GlaxoSmithKline Corporation Information
6.8.2 GlaxoSmithKline Description and Business Overview
6.8.3 GlaxoSmithKline Migraine Drugs Sales, Revenue and Gross Margin (2018-2024)
6.8.4 GlaxoSmithKline Migraine Drugs Product Portfolio
6.8.5 GlaxoSmithKline Recent Developments/Updates
6.9 Impax
6.9.1 Impax Corporation Information
6.9.2 Impax Description and Business Overview
6.9.3 Impax Migraine Drugs Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Impax Migraine Drugs Product Portfolio
6.9.5 Impax Recent Developments/Updates
6.10 Abbott
6.10.1 Abbott Corporation Information
6.10.2 Abbott Description and Business Overview
6.10.3 Abbott Migraine Drugs Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Abbott Migraine Drugs Product Portfolio
6.10.5 Abbott Recent Developments/Updates
6.11 Bayer
6.11.1 Bayer Corporation Information
6.11.2 Bayer Migraine Drugs Description and Business Overview
6.11.3 Bayer Migraine Drugs Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Bayer Migraine Drugs Product Portfolio
6.11.5 Bayer Recent Developments/Updates
6.12 Eli Lilly
6.12.1 Eli Lilly Corporation Information
6.12.2 Eli Lilly Migraine Drugs Description and Business Overview
6.12.3 Eli Lilly Migraine Drugs Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Eli Lilly Migraine Drugs Product Portfolio
6.12.5 Eli Lilly Recent Developments/Updates
6.13 Ethypharm
6.13.1 Ethypharm Corporation Information
6.13.2 Ethypharm Migraine Drugs Description and Business Overview
6.13.3 Ethypharm Migraine Drugs Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Ethypharm Migraine Drugs Product Portfolio
6.13.5 Ethypharm Recent Developments/Updates
6.14 Kowa Pharmaceuticals America
6.14.1 Kowa Pharmaceuticals America Corporation Information
6.14.2 Kowa Pharmaceuticals America Migraine Drugs Description and Business Overview
6.14.3 Kowa Pharmaceuticals America Migraine Drugs Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Kowa Pharmaceuticals America Migraine Drugs Product Portfolio
6.14.5 Kowa Pharmaceuticals America Recent Developments/Updates
6.15 Winston Pharmaceuticals
6.15.1 Winston Pharmaceuticals Corporation Information
6.15.2 Winston Pharmaceuticals Migraine Drugs Description and Business Overview
6.15.3 Winston Pharmaceuticals Migraine Drugs Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Winston Pharmaceuticals Migraine Drugs Product Portfolio
6.15.5 Winston Pharmaceuticals Recent Developments/Updates
6.16 AstraZeneca
6.16.1 AstraZeneca Corporation Information
6.16.2 AstraZeneca Migraine Drugs Description and Business Overview
6.16.3 AstraZeneca Migraine Drugs Sales, Revenue and Gross Margin (2018-2024)
6.16.4 AstraZeneca Migraine Drugs Product Portfolio
6.16.5 AstraZeneca Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Migraine Drugs Industry Chain Analysis
7.2 Migraine Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Migraine Drugs Production Mode & Process
7.4 Migraine Drugs Sales and Marketing
7.4.1 Migraine Drugs Sales Channels
7.4.2 Migraine Drugs Distributors
7.5 Migraine Drugs Customers
8 Migraine Drugs Market Dynamics
8.1 Migraine Drugs Industry Trends
8.2 Migraine Drugs Market Drivers
8.3 Migraine Drugs Market Challenges
8.4 Migraine Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Migraine Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Migraine Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Migraine Drugs Market Competitive Situation by Manufacturers in 2022
Table 4. Global Migraine Drugs Sales (K Pcs) of Key Manufacturers (2018-2024)
Table 5. Global Migraine Drugs Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Migraine Drugs Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Migraine Drugs Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Migraine Drugs Average Price (USD/Pcs) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Migraine Drugs, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Migraine Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Migraine Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Migraine Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Migraine Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Migraine Drugs as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Migraine Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 17. Global Migraine Drugs Sales by Region (2018-2024) & (K Pcs)
Table 18. Global Migraine Drugs Sales Market Share by Region (2018-2024)
Table 19. Global Migraine Drugs Sales by Region (2024-2034) & (K Pcs)
Table 20. Global Migraine Drugs Sales Market Share by Region (2024-2034)
Table 21. Global Migraine Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Migraine Drugs Revenue Market Share by Region (2018-2024)
Table 23. Global Migraine Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Migraine Drugs Revenue Market Share by Region (2024-2034)
Table 25. North America Migraine Drugs Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 26. North America Migraine Drugs Sales by Country (2018-2024) & (K Pcs)
Table 27. North America Migraine Drugs Sales by Country (2024-2034) & (K Pcs)
Table 28. North America Migraine Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Migraine Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Migraine Drugs Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Migraine Drugs Sales by Country (2018-2024) & (K Pcs)
Table 32. Europe Migraine Drugs Sales by Country (2024-2034) & (K Pcs)
Table 33. Europe Migraine Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Migraine Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Migraine Drugs Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Migraine Drugs Sales by Region (2018-2024) & (K Pcs)
Table 37. Asia Pacific Migraine Drugs Sales by Region (2024-2034) & (K Pcs)
Table 38. Asia Pacific Migraine Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Migraine Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Migraine Drugs Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Migraine Drugs Sales by Country (2018-2024) & (K Pcs)
Table 42. Latin America Migraine Drugs Sales by Country (2024-2034) & (K Pcs)
Table 43. Latin America Migraine Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Migraine Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Migraine Drugs Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Migraine Drugs Sales by Country (2018-2024) & (K Pcs)
Table 47. Middle East & Africa Migraine Drugs Sales by Country (2024-2034) & (K Pcs)
Table 48. Middle East & Africa Migraine Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Migraine Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Migraine Drugs Sales (K Pcs) by Type (2018-2024)
Table 51. Global Migraine Drugs Sales (K Pcs) by Type (2024-2034)
Table 52. Global Migraine Drugs Sales Market Share by Type (2018-2024)
Table 53. Global Migraine Drugs Sales Market Share by Type (2024-2034)
Table 54. Global Migraine Drugs Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Migraine Drugs Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Migraine Drugs Revenue Market Share by Type (2018-2024)
Table 57. Global Migraine Drugs Revenue Market Share by Type (2024-2034)
Table 58. Global Migraine Drugs Price (USD/Pcs) by Type (2018-2024)
Table 59. Global Migraine Drugs Price (USD/Pcs) by Type (2024-2034)
Table 60. Global Migraine Drugs Sales (K Pcs) by Application (2018-2024)
Table 61. Global Migraine Drugs Sales (K Pcs) by Application (2024-2034)
Table 62. Global Migraine Drugs Sales Market Share by Application (2018-2024)
Table 63. Global Migraine Drugs Sales Market Share by Application (2024-2034)
Table 64. Global Migraine Drugs Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Migraine Drugs Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Migraine Drugs Revenue Market Share by Application (2018-2024)
Table 67. Global Migraine Drugs Revenue Market Share by Application (2024-2034)
Table 68. Global Migraine Drugs Price (USD/Pcs) by Application (2018-2024)
Table 69. Global Migraine Drugs Price (USD/Pcs) by Application (2024-2034)
Table 70. Allergan Corporation Information
Table 71. Allergan Description and Business Overview
Table 72. Allergan Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 73. Allergan Migraine Drugs Product
Table 74. Allergan Recent Developments/Updates
Table 75. Merck Corporation Information
Table 76. Merck Description and Business Overview
Table 77. Merck Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 78. Merck Migraine Drugs Product
Table 79. Merck Recent Developments/Updates
Table 80. Pfizer Corporation Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 83. Pfizer Migraine Drugs Product
Table 84. Pfizer Recent Developments/Updates
Table 85. Teva Corporation Information
Table 86. Teva Description and Business Overview
Table 87. Teva Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 88. Teva Migraine Drugs Product
Table 89. Teva Recent Developments/Updates
Table 90. Pfizer Corporation Information
Table 91. Pfizer Description and Business Overview
Table 92. Pfizer Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 93. Pfizer Migraine Drugs Product
Table 94. Pfizer Recent Developments/Updates
Table 95. Johnson & Johnson Corporation Information
Table 96. Johnson & Johnson Description and Business Overview
Table 97. Johnson & Johnson Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 98. Johnson & Johnson Migraine Drugs Product
Table 99. Johnson & Johnson Recent Developments/Updates
Table 100. Endo International Corporation Information
Table 101. Endo International Description and Business Overview
Table 102. Endo International Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 103. Endo International Migraine Drugs Product
Table 104. Endo International Recent Developments/Updates
Table 105. GlaxoSmithKline Corporation Information
Table 106. GlaxoSmithKline Description and Business Overview
Table 107. GlaxoSmithKline Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 108. GlaxoSmithKline Migraine Drugs Product
Table 109. GlaxoSmithKline Recent Developments/Updates
Table 110. Impax Corporation Information
Table 111. Impax Description and Business Overview
Table 112. Impax Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 113. Impax Migraine Drugs Product
Table 114. Impax Recent Developments/Updates
Table 115. Abbott Corporation Information
Table 116. Abbott Description and Business Overview
Table 117. Abbott Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 118. Abbott Migraine Drugs Product
Table 119. Abbott Recent Developments/Updates
Table 120. Bayer Corporation Information
Table 121. Bayer Description and Business Overview
Table 122. Bayer Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 123. Bayer Migraine Drugs Product
Table 124. Bayer Recent Developments/Updates
Table 125. Eli Lilly Corporation Information
Table 126. Eli Lilly Description and Business Overview
Table 127. Eli Lilly Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 128. Eli Lilly Migraine Drugs Product
Table 129. Eli Lilly Recent Developments/Updates
Table 130. Ethypharm Corporation Information
Table 131. Ethypharm Description and Business Overview
Table 132. Ethypharm Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 133. Ethypharm Migraine Drugs Product
Table 134. Ethypharm Recent Developments/Updates
Table 135. Kowa Pharmaceuticals America Corporation Information
Table 136. Kowa Pharmaceuticals America Description and Business Overview
Table 137. Kowa Pharmaceuticals America Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 138. Kowa Pharmaceuticals America Migraine Drugs Product
Table 139. Kowa Pharmaceuticals America Recent Developments/Updates
Table 140. Winston Pharmaceuticals Corporation Information
Table 141. Winston Pharmaceuticals Description and Business Overview
Table 142. Winston Pharmaceuticals Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 143. Winston Pharmaceuticals Migraine Drugs Product
Table 144. Winston Pharmaceuticals Recent Developments/Updates
Table 145. AstraZeneca Corporation Information
Table 146. AstraZeneca Description and Business Overview
Table 147. AstraZeneca Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 148. AstraZeneca Migraine Drugs Product
Table 149. AstraZeneca Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Migraine Drugs Distributors List
Table 153. Migraine Drugs Customers List
Table 154. Migraine Drugs Market Trends
Table 155. Migraine Drugs Market Drivers
Table 156. Migraine Drugs Market Challenges
Table 157. Migraine Drugs Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Migraine Drugs
Figure 2. Global Migraine Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Migraine Drugs Market Share by Type in 2022 & 2034
Figure 4. Sumatriptan Product Picture
Figure 5. Zolmitriptan Product Picture
Figure 6. Rizatriptan Product Picture
Figure 7. Others Drug Product Picture
Figure 8. Global Migraine Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Migraine Drugs Market Share by Application in 2022 & 2034
Figure 10. Hospitals
Figure 11. Clinics
Figure 12. Household Use
Figure 13. Others
Figure 14. Global Migraine Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 15. Global Migraine Drugs Market Size (2018-2034) & (US$ Million)
Figure 16. Global Migraine Drugs Sales (2018-2034) & (K Pcs)
Figure 17. Global Migraine Drugs Average Price (USD/Pcs) & (2018-2034)
Figure 18. Migraine Drugs Report Years Considered
Figure 19. Migraine Drugs Sales Share by Manufacturers in 2022
Figure 20. Global Migraine Drugs Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest Migraine Drugs Players: Market Share by Revenue in 2022
Figure 22. Migraine Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 23. Global Migraine Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Figure 24. North America Migraine Drugs Sales Market Share by Country (2018-2034)
Figure 25. North America Migraine Drugs Revenue Market Share by Country (2018-2034)
Figure 26. U.S. Migraine Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 27. Canada Migraine Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. Europe Migraine Drugs Sales Market Share by Country (2018-2034)
Figure 29. Europe Migraine Drugs Revenue Market Share by Country (2018-2034)
Figure 30. Germany Migraine Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. France Migraine Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. U.K. Migraine Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 33. Italy Migraine Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. Russia Migraine Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Asia Pacific Migraine Drugs Sales Market Share by Region (2018-2034)
Figure 36. Asia Pacific Migraine Drugs Revenue Market Share by Region (2018-2034)
Figure 37. China Migraine Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Japan Migraine Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. South Korea Migraine Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. India Migraine Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Australia Migraine Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Taiwan Migraine Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Indonesia Migraine Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Thailand Migraine Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Malaysia Migraine Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Philippines Migraine Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Latin America Migraine Drugs Sales Market Share by Country (2018-2034)
Figure 48. Latin America Migraine Drugs Revenue Market Share by Country (2018-2034)
Figure 49. Mexico Migraine Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 50. Brazil Migraine Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Argentina Migraine Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. Middle East & Africa Migraine Drugs Sales Market Share by Country (2018-2034)
Figure 53. Middle East & Africa Migraine Drugs Revenue Market Share by Country (2018-2034)
Figure 54. Turkey Migraine Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 55. Saudi Arabia Migraine Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 56. U.A.E Migraine Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 57. Global Sales Market Share of Migraine Drugs by Type (2018-2034)
Figure 58. Global Revenue Market Share of Migraine Drugs by Type (2018-2034)
Figure 59. Global Migraine Drugs Price (USD/Pcs) by Type (2018-2034)
Figure 60. Global Sales Market Share of Migraine Drugs by Application (2018-2034)
Figure 61. Global Revenue Market Share of Migraine Drugs by Application (2018-2034)
Figure 62. Global Migraine Drugs Price (USD/Pcs) by Application (2018-2034)
Figure 63. Migraine Drugs Value Chain
Figure 64. Migraine Drugs Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed